Support Groups Get Busy in July
In the month of July - on July 20, in fact, big support group events are coming in San Francisco and Marin Counties. Marin:
A new support group is being organized in Marin, and the first meeting is on July 20.
DATE: Saturday, July 20
TIME: 10 am to 12 noon
PLACE: 401 Ash St, Apt 10, Mill Valley, CA 94941
HOST: Marilyn Wedner
If you have any questions, please e-mail or call
San Francisco:
The SF Subchapter is organizing a lupus education day on July 20.
DATE: Saturday, July 20.
TIME: 12 noon to 4 pm.
PLACE: Kaiser Medical Center, 2238 Geary Blvd @ Divisadero, 3rd Floor, Diamond Conference Room San Francisco, CA 94115
CONTACT: Evanne Grate. 415.452.4270 or egrate@comcast.net
|
Information contained in this e-Newsletter should not be considered a substitute for professional diagnosis, treatment or management of S.L.E. and symptoms by a physician.
Missed a previous issue of this e-Newsletter? You can now view our ARCHIVES.
Editor: Spandan Chakrabarti
|
Connect with us on
via "Lupus Online"
|
LFNC is an active partner in
|
|
|
|
You are receiving this newsletter because you have subscribed or have participated in our programs or events. We respect your time and privacy. If you prefer not to continue receiving the newsletter, you can click on the "safe unsubscribe" button below. We hope, however, that you will opt to remain on our newsletter list for important information and life-saving tips that you or someone you know may benefit from now or in the future.
|
International Abortion Controversy Sparks Interest in Lupus and Pregnancy
 Earlier this month, a Salvadoran woman with lupus, known publicly only as Beatrice, made headlines when El Salvador's highest court rejected her plea for an abortion - a procedure that is banned under the laws of this Central American country. Beatrice's appeal was based on what medical doctors said was a risk to her life should she continue with the pregnancy. Doctors had also determined that her baby had no chance of survival because of a severe brain defect. Eventually, in a round-about way to avoid violating the law, doctors performed an "induced delivery" to save the woman's life. The fetus was delivered by Caesarean section, placed in an incubator and provided fluids. It lived for five hours. The news surrounding Beatrice has certainly invoked discussion about lupus and pregnancy. While many lupus patients have had and continue to have successful pregnancies, this involves personal decisions that patients and families must make in close consultation with their doctors. Here's some useful information about lupus and pregnancy, as discussed in WebMD's web site:
As always, it is best for lupus patients to discuss their particular situation with their medical providers. |
Fund Campaign - So Close!

Our yearly Fund Campaign begins and closes with our fiscal year, July 1 through June 30. The Fund Campaign is unique in its value to keep the operations going at the Lupus Foundation because it comes directly from your generosity and your commitment to the cause of patient programs and lupus research. Our fiscal year is coming to a close, and so is the Fund Campaign. We are less than $4,500 away from our $35,000 goal.
Every dollar helps!
|
Investigational Drug Shows Promise in New Study
 The Lupus Research Institute reported last week that the investigational lupus drug Epratuzumab - currently in its phase III clinical trials - has shown early promise.
From a press release on the study:
In this preclinical study, treatment of peripheral blood mononuclear cells (PBMCs) with epratuzumab significantly reduced the levels of select B-cell surface proteins, including CD22, CD19, CD21 and CD79b. Corroboratively, SLE patients on epratuzumab therapy also showed significantly lower levels of CD22, CD19 and CD21, compared to treatment-naïve patients. Although internalization of CD22 upon epratuzumab binding is known and expected, reduction of the other BCR proteins presents a new finding. The reduction of CD19 is of particular interest since elevated levels of this protein on the surface of B cells have been implicated in SLE.
|
LFNC's Social Media Program is funded through a generous grant from THE HENRY L. GUENTHER FOUNDATION GEORGE H. SANDY FOUNDATION GLAXOSMITHKLINE |
|
|
|
|